New drug aims to fight cancer while protecting the heart
Disease control
Recruiting now
This is a first-in-human study to test the safety of a new drug called RC220 when given with the common chemotherapy drug doxorubicin. It will involve about 53 adults with advanced solid tumors who may benefit from anthracycline treatment. The main goals are to find the safest do…
Phase: PHASE1 • Sponsor: Race Oncology Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC